Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailAntipodean Dialogue: Randolph Stow and David Malouf
Delrez, Marc ULg

in Davis, Geoffrey V.; Maes-Jelinek, Hena (Eds.) Crisis and Creativity in the New Literatures in English (1990)

Detailed reference viewed: 36 (1 ULg)
Full Text
Peer Reviewed
See detailAntiproliferative and genotoxic effects of Mikania glomerata (Asteraceae)
Dalla Nora, G; Pastori, T; Laughinghouse IV, Haywood ULg et al

in Biocell : Official Journal of the Sociedades Latinoamericanas de Microscopia Electronica ... Et. Al (2010), 34(3), 95-101

Detailed reference viewed: 25 (0 ULg)
Full Text
Peer Reviewed
See detailAntiproliferative effect of the arboreal and medicinal species Luehea divaricata on the Allium cepa cell cycle
Frescura, VDS; Laughinghouse IV, Haywood ULg; Tedesco, SB

in Caryologia : Giornale di Citologia, Citosistematica, e Citogenetica (2012), 65(1), 27-33

Detailed reference viewed: 32 (2 ULg)
Full Text
Peer Reviewed
See detailAntiproton and Antilambda Annihilations on Several Nucleons
Cugnon, Joseph ULg; Vandermeulen, Jacques

in Physical Review. C : Nuclear Physics (1989), 39

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailAntiproton Annihilation at Rest on Light Nuclei : Rescattering, Strange Particle Yield and B = 1 Annihilation
Cugnon, Joseph ULg; Deneye, Pierre; Vandermeulen, Jacques

in Nuclear Physics A (1990), 517

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailAntiproton Annihilation Inside Nuclei
Cugnon, Joseph ULg; Cahay, M.; jasselette, Pierre et al

in Physics Letters B (1982), 115

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailAntiproton Annihilation on Nuclei
Cugnon, Joseph ULg

in Bunce, G.M. (Ed.) Proceedings of the Third International Conference on the Intersections Between Nuclei and Particles (1988)

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailAntiproton-Nucleus Annihilation
Cugnon, Joseph ULg

in Richard, Jean-Marc; Aslanidès, E.; Boccara, N. (Eds.) The Elementary Structure of Matter (1988)

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailAntiproton-Nucleus Interaction
Cugnon, Joseph ULg; Vandermeulen, Jacques

in Annales de Physique Fr. (1989), 14

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailAntiprotozoal and cytotoxic triterpenoid saponins from the roots of Cephalaria gigantea
Tabatadze, Nino; Elias, Riad; Delmas, F. et al

Poster (2006, July)

Detailed reference viewed: 45 (0 ULg)
See detailL'antipsychiatre et la plume
Tilkin, Françoise ULg

in Revue belge de philologie et d'histoire (1982), 60(4), 1083-1084

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailL'antipsychologisme de Brentano
Boccaccini, Federico ULg

in Gyemant, Maria (Ed.) Psychologie et psychologisme (2015)

Detailed reference viewed: 53 (8 ULg)
Full Text
Peer Reviewed
See detailAntipsychotics and Neuropeptides: The Atypical Profile of Ci-943 and Its Relationship to Neurotensin
Liégeois, Jean-François ULg; Bonaventure, P.; Delarge, J. et al

in Neuroscience & Biobehavioral Reviews (1995), 19(4, Winter), 519-31

CI-943 is a new drug candidate with antipsychotic-like activity in a variety of behavioural tests in rodents and primates, but without any affinity for brain dopamine receptors. CI-943 does not cause ... [more ▼]

CI-943 is a new drug candidate with antipsychotic-like activity in a variety of behavioural tests in rodents and primates, but without any affinity for brain dopamine receptors. CI-943 does not cause dystonia in monkeys, a predictive symptom of extrapyramidal side effects (EPS). Its mechanism of action remains unclear. Neurotensin (NT) concentration in nucleus accumbens and caudate is increased by CI-943; this may be associated with its antipsychotic effect. Indeed various observations suggest that the clinical action of antipsychotic drugs may at least be partially mediated by some neuropeptides. Various actions of neurotensin are reviewed. The hypothesis on the role of neurotensin represents a new strategy in the development of pharmacological tools for the treatment of schizophrenia. [less ▲]

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailLes antipsychotiques atypiques dans la dépression résistante
PITCHOT, William ULg; Constant E; Floris M et al

in Acta Psychiatrica Belgica (2012)

Detailed reference viewed: 21 (1 ULg)
See detailL'antiquité classique comme source d'inspiration dans l'oeuvre de Karel Tchapek
Mouton, Charles ULg

in Slavica Gandensia (1993), 20

Detailed reference viewed: 69 (2 ULg)
See detailL’Antiquité et le Moyen Âge
Jadoulle, Jean-Louis ULg; Hasquin, Hervé

Book (2008)

Detailed reference viewed: 19 (3 ULg)
Full Text
See detailAntiquité tardive et christianisme africains dans l'Africa romana : un bilan historiographique
Fialon, Sabine ULg

in Ruggeri, Paola (Ed.) L’Africa romana XX. Momenti di continuita e rottura : bilancio di 30 anni di convegni de l’Africa romana (2016)

Detailed reference viewed: 50 (3 ULg)
Full Text
Peer Reviewed
See detailAntireflective subwavelength patterning of IR optics
Vandormael, Denis; Habraken, Serge ULg; Loicq, Jerôme ULg et al

in Proceedings of SPIE (2006), 6395

Thermal infrared (IR) lenses require efficient anti-reflection coating. Moth-eye (or egg-box) 2D subwavelength gratings have demonstrated their ability to reach a very high transmission for a wide ... [more ▼]

Thermal infrared (IR) lenses require efficient anti-reflection coating. Moth-eye (or egg-box) 2D subwavelength gratings have demonstrated their ability to reach a very high transmission for a wide wavelength and angular range. The use in thermal IR is simplified by the lower resolution for lithographic technology, compared to visible waveband. However, deeper structures must be engraved and lithography must be adapted to IR materials. In order to be cost-effective, the patterning must be produced by replication techniques, such as embossing. Our laboratory is now experimenting hot embossing of moth-eye patterns in chalcogenide substrates. In this paper, theoretical analysis, micro-lithographic technology and manufacturing processes are detailed. [less ▲]

Detailed reference viewed: 67 (6 ULg)
Full Text
Peer Reviewed
See detailAntiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis.
Reginster, Jean-Yves ULg; Neuprez, A.; Beaudart, Charlotte ULg et al

in Drugs & aging (2014), 31

Osteoporotic fractures are a major cause of morbidity in the elderly population. Since postmenopausal osteoporosis is related to an increase in osteoclastic activity at the time of menopause, inhibitors ... [more ▼]

Osteoporotic fractures are a major cause of morbidity in the elderly population. Since postmenopausal osteoporosis is related to an increase in osteoclastic activity at the time of menopause, inhibitors of bone resorption have genuinely been considered an adequate strategy for prevention and treatment of osteoporosis. Bisphosphonates and selective oestrogen receptor modulators are widely prescribed to treat osteoporosis. However, other antiresorptive drugs have been developed for the management of osteoporosis, with the objective of providing a substantial reduction in osteoporotic fractures at all skeletal sites, combined with an acceptable long-term skeletal and systemic safety profile. Denosumab, a human monoclonal antibody to receptor activator for nuclear factor kappa B ligand, has shown efficacy against vertebral, nonvertebral and hip fractures. Its administration every 6 months as a subcutaneous formulation might significantly influence compliance and persistence to therapy. Additional results regarding long-term skeletal safety (i.e. osteonecrosis of the jaw and atypical diaphyseal femoral fracture) are needed. Odanacatib, a selective cathepsin K inhibitor, is a promising new approach to the inhibition of osteoclastic resorption, with the potential to uncouple bone formation from bone resorption. Results regarding its anti-fracture efficacy are expected in the coming months. [less ▲]

Detailed reference viewed: 32 (10 ULg)